Is Amrize AG (AMRZ) Overvalued?
We dive into why Amrize AG (AMRZ) could be considered overvalued on 2026-07-17, based on AAII’s Value Score and Grade.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhesives, tapes, and sealants. The company was formerly known as Holcim North America Finance Ltd and changed its name to Amrize AG in December 2013. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland.
Commentary & Analysis
Why Amrize AG’s (AMRZ) Stock Is Down 6.59%
As of Tuesday, July 07, Amrize AG’s AMRZ share price has dipped by 6.59%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Amrize AG’s (AMRZ) Stock Is Down 5.30%
As of Monday, June 29, Amrize AG’s AMRZ share price has dipped by 5.30%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Does Amrize AG (AMRZ) Have Momentum?
With data as of June 23, 2026, we examine if Amrize AG(AMRZ) is consistently building momentum based on AAII's A+ Investor Momentum and Value Scores and Grades.Michael Rose
What You Need to Know About Amrize AG's Q2 Earnings
Amrize AG's fiscal Q2 earnings report was released on Wednesday, April 29. Let's dive in to see if (AMRZ) missed or beat analyst's expectations.Tudor Pop
Financial Summary
| Share Statistics | AMRZ | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $27,170.1 | $3,483.4 | 89% |
|
| Shares Out (Mil) | 553.2 | 97.4 | 90% |
|
| Institutional Ownership | 86.8% | 62.8% | 55% |
|
| Float (Mil) | 493.2 | 117.0 | 85% |
|
| Beta | na | 0.74 | na |
|
| Avg Daily Volume (000s) | 2,790 | 50 | 87% |
|
| Price Change (52-week) |
(6.0%) | 76.0% | 40% |
|
| Growth | AMRZ | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 5.0% | na |
|
| Net Income (5yr) | na | 9.5% | na |
|
| EPS (5yr) | na | 10.6% | na |
|
| Dividends (5yr) | na | 0.0% | 68% |
|
| Cash Flow (5yr) | na | (15.8%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 14 | 15 | |
| Current EPS | $0.951 | $2.800 | $3.184 | |
| Month Ago EPS | $0.966 | $2.814 | $3.186 | |
| # Rev Up | 0 | 2 | 0 | |
| # Rev Down | 1 | 1 | 2 | |
| Three Months Ago EPS | $0.965 | $2.758 | $3.164 | |
| Year/Year Chg | (552.9%) | 30.8% | 70.1% | |
| Financials | AMRZ | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $11,912 | $4,275 | 86% |
|
| Net Income (TTM) (Mil) | $1,156 | $153 | 88% |
|
| EPS (TTM) | $2.090 | $0.900 | 72% |
|
| Operating Cash Flow (TTM) (Mil) | $2,168 | $611 | 89% |
|
| Net Cash Flow (TTM) (Mil) | $525 | $4 | 91% |
|
| Long-Term Debt (Q1) (Mil) | $5,740 | $1,676 | 87% |
|
| Enterprise Value (Q1) (Mil) | $34,396 | $5,556 | 89% |
|
| Valuation | AMRZ | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.07 | 2.66 | 52% |
|
| P/E | 23.4 | 26.1 | 58% |
|
| Dividend Yield | 0.9% | 0.3% | 66% |
|
| PEG (5yr hist) | na | 2.0 | na |
|
| Ratios | AMRZ | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 25.4% | 30.5% | 29% |
|
| Net Margin | 9.7% | 8.2% | 62% |
|
| ROA | 4.9% | 3.6% | 72% |
|
| ROE | 10.1% | 8.0% | 58% |
|
| Liabilities to Assets | 46.1% | 48.3% | 37% |
|
| F-Score | 3 | 5 | 19% |
|
Amrize AG did not pass any screens on 7/31/2026.
